Elon Musk's company, Neuralink, which focuses on developing brain-computer interfaces, recently received FDA approval for its first human clinical trial, a notable achievement after seven years of research and development. Neuralink's device aims to allow humans to control electronic devices using thoughts by interpreting brain signals.

While the technology promises transformative benefits, especially for those with motor disabilities, it hasn't been without controversy. In 2021, concerns arose due to complications in animal trials, leading to ethical questions. Nonetheless, successes, like enabling a monkey named Sake to request snacks using his mind, showcased its potential. Beyond device control, Neuralink aspires to restore or even introduce vision by directly stimulating the brain using a camera-based system, offering hope for the visually impaired.

The FDA's approval was met with varied responses, reflecting both excitement and apprehension based on Neuralink's past issues. The upcoming PRIME Study will focus on assessing the implant's safety and effectiveness in letting paralyzed individuals control external gadgets. As Neuralink heads towards its human trials, it stands at the cusp of potentially revolutionizing medical and technological landscapes.

Join our YouTube channel by clicking here: [ Ссылка ]

Find us on Instagram: [ Ссылка ]
Find us on Facebook: [ Ссылка ]
Find us on Twitter: [ Ссылка ]
Find us on TikTok: [ Ссылка ]

Get the latest stories: [ Ссылка ]

Support IE for high-quality journalism: [ Ссылка ]

свернуть